Tiny Health

Tiny Health is a verified, high-traction scaleup with approximately $5.7M in annual revenue and $13M+ in funding (Series A), significantly exceeding the baseline. The company offers at-home gut microbiome sequencing (shotgun metagenomics) for infants and families, addressing a clear real-world problem (chronic conditions like eczema/allergies). While the submission form itself was poor (containing hyperbolic claims like 'everyone' and 'most people', and missing revenue data), external validation confirms a team of ~41 people and over 25,000 families served. The high score reflects the strong business fundamentals and technical validity, despite the low-quality submission text.